Expression of programmed death-ligand 1 and programmed death-1 in patients with extramammary paget's disease

Background: Extramammary Paget's disease (EMPD) is a rare skin cancer and sometimes has fatal prognosis. For progressive cases, therapeutic options are limited. In recent years, treatment with an anti-programmed death-1 (PD-1) antibody has improved the prognosis of various malignancies. In addi...

Full description

Bibliographic Details
Main Authors: Hiroyuki Goto, Kazunari Sugita, Osamu Yamamoto
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Indian Journal of Dermatology
Subjects:
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2021;volume=66;issue=2;spage=169;epage=173;aulast=Goto